Aspire Biopharma agrees to sale to FireFish TopCo in asset purchase deal

Aspire Biopharma Holdings entered into a purchase agreement with FireFish TopCo, LLC dated June 10, 2026, transferring equity interests and related assets. The transaction includes representations, warranties, closing conditions and post-closing covenants typical of M&A activity in the biopharmaceutical sector.